Brand Post May 26, 2024 /R E M I N D E R — Media Advisory – Prime Minister’s itinerary for Sunday, May 26, 2024/ OTTAWA, ON, May 25, 2024 /CNW/ – Note: All times local National Capital Region, Canada No public events scheduled This…
Brand Post May 26, 2024 Global Times: Expanding population of wild Asian elephants in Yunnan are living symbols of China’s ecological commitment BEIJING, May 26, 2024 /PRNewswire/ — Li Shengqian, an elephant ranger, walked through a large area of flattened cornfields. He…
Brand Post May 26, 2024 Snapmaker Celebrates 8th Anniversary with Play Well Makerathon, Artisan Premium, and More SHENZHEN, China, May 26, 2024 /PRNewswire/ — Snapmaker, a leading innovator in the 3-in-1 3D printer market, is thrilled to…
Brand Post May 25, 2024 Greg Walter Named President of Charlotte Motor Speedway Click here for a high-resolution photo to support this release. CONCORD, N.C., May 25, 2024 /PRNewswire/ — Today, Greg Walter,…
Brand Post May 25, 2024 Media Advisory – Prime Minister’s itinerary for Sunday, May 26, 2024 OTTAWA, ON, May 25, 2024 /CNW/ – Note: All times local National Capital Region, Canada No public events scheduled This…
Brand Post May 25, 2024 NASA Launches Small Climate Satellite to Study Earth’s Poles WASHINGTON, May 25, 2024 /PRNewswire/ — The first of a pair of climate satellites designed to study heat emissions at…
Brand Post May 25, 2024 Statement by the Prime Minister on Africa Day OTTAWA, ON, May 25, 2024 /CNW/ – The Prime Minister, Justin Trudeau, today issued the following statement on Africa Day:…
Brand Post May 25, 2024 DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Teladoc Health NEW YORK, May 25, 2024 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential…
Brand Post May 25, 2024 /R E M I N D E R — Media Advisory – Prime Minister’s itinerary for Saturday, May 25, 2024/ OTTAWA, ON, May 24, 2024 /CNW/ – Note: All times local Greater Halifax Area, Nova Scotia 10:00 a.m. …
Brand Post May 25, 2024 HI-Bio Announces Positive Results from Phase 2 Study of Felzartamab for Late Antibody-Mediated Rejection in Kidney Transplant Recipients 82% (n=9/11) of patients on felzartamab experienced resolution of antibody-mediated rejection per Banff criteria on biopsy at 24 weeks versus…